Multivariate analysis of clinical prognostic factors in children with intracranial ependymomas
- PMID: 15332330
- DOI: 10.1023/b:neon.0000033383.84900.c1
Multivariate analysis of clinical prognostic factors in children with intracranial ependymomas
Abstract
The optimal postoperative management of pediatric intracranial ependymomas is controversial. We analyzed clinical prognostic factors for their influence on outcome in such children. Our retrospective series included 15 with supratentorial and 28 with infratentorial tumors. Twenty ependymomas were grade II, and 23 were anaplastic. Complete resection was performed in 18 patients, incomplete resection in 19, and stereotactic biopsy in 6. Radiotherapy was done in 31 patients and chemotherapy in 13. The surviving patients have been followed 8-232 months (median: 69 months). The median survival time was 30 months, and 5-year overall survival and progression-free survival rates were 53.9% and 45.9%, respectively. By tumor site: supratentorial, 56.6% and 50.9%; infratentorial, 52.3% and 42.5%. Multivariate analysis identified complete resection (5-year progression-free survival, 71.8%) and age <3 years old as significant favorable and adverse prognostic features (relative risk, 2.59; 95% CI, 1.05-6.38), respectively. Twenty-six children relapsed 1-107 months after diagnosis (median: 12 months). Relapses were local in 22 cases, and combined local and distant in three cases. Only one of 15 patients with supratentorial tumors developed isolated spinal metastasis. Failure at the primary site is the major obstacle to improve cure rates. The extent of surgical resection and age were the only statistically significant prognostic factors.
Similar articles
-
Supratentorial extraventricular ependymomas: A retrospective study focused on long-term outcomes and prognostic factors.Clin Neurol Neurosurg. 2018 Feb;165:1-6. doi: 10.1016/j.clineuro.2017.12.013. Epub 2017 Dec 13. Clin Neurol Neurosurg. 2018. PMID: 29253745
-
[Prognostic factors and results after the combined surgical and radiotherapy treatment of ependymomas].Strahlenther Onkol. 1992 Dec;168(12):679-85. Strahlenther Onkol. 1992. PMID: 1481116 German.
-
Ependymoma: results, prognostic factors and treatment recommendations.Int J Radiat Oncol Biol Phys. 1998 Mar 1;40(4):845-50. doi: 10.1016/s0360-3016(97)00893-6. Int J Radiat Oncol Biol Phys. 1998. PMID: 9531369 Review.
-
Treatment and survival of supratentorial and posterior fossa ependymomas in adults.J Clin Neurosci. 2016 Jun;28:24-30. doi: 10.1016/j.jocn.2015.11.014. Epub 2016 Jan 19. J Clin Neurosci. 2016. PMID: 26810473
-
Supratentorial hemispheric ependymomas: an analysis of 109 adults for survival and prognostic factors.J Neurosurg. 2016 Aug;125(2):410-8. doi: 10.3171/2015.7.JNS151187. Epub 2016 Jan 8. J Neurosurg. 2016. PMID: 26745489 Review.
Cited by
-
Proton radiotherapy for pediatric central nervous system ependymoma: clinical outcomes for 70 patients.Neuro Oncol. 2013 Nov;15(11):1552-9. doi: 10.1093/neuonc/not121. Epub 2013 Oct 6. Neuro Oncol. 2013. PMID: 24101739 Free PMC article.
-
Rethinking childhood ependymoma: a retrospective, multi-center analysis reveals poor long-term overall survival.J Neurooncol. 2017 Oct;135(1):201-211. doi: 10.1007/s11060-017-2568-8. Epub 2017 Jul 21. J Neurooncol. 2017. PMID: 28733870 Free PMC article.
-
Intracranial ependymomas treated with radiotherapy: long-term results from a single institution.J Neurooncol. 2011 May;102(3):451-7. doi: 10.1007/s11060-010-0344-0. Epub 2010 Aug 13. J Neurooncol. 2011. PMID: 20706771 Clinical Trial.
-
Three-dimensional conformal radiation therapy for ependymoma.Childs Nerv Syst. 2009 Oct;25(10):1261-8. doi: 10.1007/s00381-009-0892-9. Epub 2009 Apr 17. Childs Nerv Syst. 2009. PMID: 19373477
-
Patterns of relapse for children with localized intracranial ependymoma.J Neurooncol. 2018 Jun;138(2):435-445. doi: 10.1007/s11060-018-2815-7. Epub 2018 Mar 6. J Neurooncol. 2018. PMID: 29511977 Free PMC article.
References
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources